Month: January 2026

It is with profound sadness and the deepest respect that AIBILI announces the passing of our beloved Founder and Honorary President, Prof. José Cunha-Vaz.
The world has lost a true pioneer in the field of Ophthalmology. Prof. José Cunha-Vaz was more than a world-class medical doctor and researcher. He was a visionary who dedicated his life to the gift of sight. His groundbreaking contributions reshaped modern eye care and earned him a place as a global reference in the medical community.
For those of us at AIBILI, he was much more than a founder. He was a mentor who led with both brilliance and heart. Until today, he remained a constant source of inspiration, working closely with our teams and instilling a culture of excellence that defines us today.
Our deepest condolences go out to his family, friends, and all those who had the privilege of working alongside him.
Rest in peace, Prof. Cunha-Vaz. You will be deeply missed, but never forgotten.

AIBILI is pleased to announce the appointment of Daniel Sanches Fernandes as its new Chief Executive Officer, succeeding Cecília Martinho and building on her dedicated leadership and significant contributions to the institution.

With more than 20 years of experience in health research and development, project management, and technology transfer, the new CEO brings strong expertise and a clear vision to further strengthen AIBILI’s role in clinical and translational research. This leadership marks an important step in deepening the institution’s contribution to advancing human health and well-being.

Working closely with AIBILI’s teams and partners, the CEO will continue to focus on transforming research outcomes into impactful innovations that reach people, create value, and generate positive outcomes for the region and beyond.

AIBILI remains committed to collaboration and partnership and welcomes dialogue with organizations and stakeholders interested in joint projects and shared innovation goals.